Skip to main content

Animations

MJFF Publications

6401 - 6410 of 8823 Results
Title
Year
  • Year
  • 2022
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domains
    Journal Name: PLOS Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pbio.3001427
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00219-1
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Diffusion along perivascular spaces reveals evidence supportive of glymphatic function impairment in Parkinson disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.004
    Citation Count: 138
  • Summary Details
    OPEN
    Title: Mapping autonomic, mood and cognitive effects of hypothalamic region deep brain stimulation
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awab170
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Serum Neurofilament Light is elevated in COVID-19 Positive Adults in the ICU and is associated with Co-Morbid Cardiovascular Disease, Neurological Complications, and Acuity of Illness
    Journal Name: Cardiology and Cardiovascular Medicine
    Publisher: Fortune Journals
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.26502/fccm.92920221
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-26066-5
    Citation Count: 215
  • Summary Details
    OPEN
    Title: Humanized Biomimetic Nanovesicles for Neuron Targeting
    Journal Name: Advanced Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/advs.202101437
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0257372
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Oromandibular Dystonia: A Clinical Examination of 2,020 Cases
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2021.700714
    Citation Count: 34
  • Summary Details
    OPEN
    Title: The AKT modulator A-443654 reduces α-synuclein expression and normalizes ER stress and autophagy
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jbc.2021.101191
    Citation Count: 36
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.